Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.

MLA

García-Pardo, Miguel, et al. “Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.” JAMA Network Open, vol. 6, no. 7, July 2023, p. e2325332. EBSCOhost, https://doi.org/10.1001/jamanetworkopen.2023.25332.

APA

García-Pardo, M., Czarnecka-Kujawa, K., Law, J. H., Salvarrey, A. M., Fernandes, R., Fan, Z. J., Waddell, T. K., Yasufuku, K., Liu, G., Donahoe, L. L., Pierre, A., Le, L. W., Gunasegaran, T., Ghumman, N., Shepherd, F. A., Bradbury, P. A., Sacher, A. G., Schmid, S., Corke, L., … Leighl, N. B. (2023). Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial. JAMA Network Open, 6(7), e2325332. https://doi.org/10.1001/jamanetworkopen.2023.25332

Chicago

García-Pardo, Miguel, Kasia Czarnecka-Kujawa, Jennifer H Law, Alexandra M Salvarrey, Roxanne Fernandes, Zhen J Fan, Thomas K Waddell, et al. 2023. “Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.” JAMA Network Open 6 (7): e2325332. doi:10.1001/jamanetworkopen.2023.25332.